Bioton S.a.
BIO.WA · WSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | PLN 208 | PLN 182 | PLN 233 | PLN 163 |
| % Growth | 14.4% | -22.1% | 43% | – |
| Cost of Goods Sold | PLN 143 | PLN 109 | PLN 137 | PLN 85 |
| Gross Profit | PLN 65 | PLN 73 | PLN 96 | PLN 76 |
| % Margin | 31.2% | 40.1% | 41.1% | 46.8% |
| R&D Expenses | PLN 4 | PLN 6 | PLN 5 | PLN 5 |
| G&A Expenses | PLN 31 | PLN 30 | PLN 30 | PLN 28 |
| SG&A Expenses | PLN 67 | PLN 71 | PLN 65 | PLN 60 |
| Sales & Mktg Exp. | PLN 36 | PLN 41 | PLN 35 | PLN 32 |
| Other Operating Expenses | -PLN 1 | -PLN 19 | PLN 4 | -PLN 1 |
| Operating Expenses | PLN 71 | PLN 58 | PLN 74 | PLN 63 |
| Operating Income | -PLN 6 | PLN 15 | PLN 21 | PLN 14 |
| % Margin | -2.7% | 8.4% | 9.1% | 8.8% |
| Other Income/Exp. Net | -PLN 6 | -PLN 8 | -PLN 16 | -PLN 6 |
| Pre-Tax Income | -PLN 12 | PLN 7 | PLN 5 | PLN 8 |
| Tax Expense | PLN 4 | PLN 5 | PLN 4 | PLN 5 |
| Net Income | -PLN 16 | PLN 2 | PLN 1 | PLN 3 |
| % Margin | -7.5% | 1.3% | 0.6% | 1.8% |
| EPS | -0.18 | 0.027 | 0.017 | 0.034 |
| % Growth | -779.2% | 60.6% | -50.9% | – |
| EPS Diluted | -0.18 | 0.027 | 0.017 | 0.034 |
| Weighted Avg Shares Out | 86 | 86 | 86 | 86 |
| Weighted Avg Shares Out Dil | 86 | 86 | 86 | 86 |
| Supplemental Information | – | – | – | – |
| Interest Income | PLN 2 | PLN 0 | PLN 8 | PLN 5 |
| Interest Expense | PLN 8 | PLN 8 | PLN 8 | PLN 5 |
| Depreciation & Amortization | PLN 36 | PLN 35 | PLN 34 | PLN 32 |
| EBITDA | PLN 33 | PLN 31 | PLN 59 | PLN 45 |
| % Margin | 15.7% | 17.2% | 25.1% | 27.7% |